GlassScriptPhysician profile
Francine Fradella
NPI 1962420851
$2,069.21
in general payments reported to CMS, 2019-2025
24 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.52 · 2020: $369 · 2021: $575 · 2022: $468 · 2023: $160 · 2024: $180 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $59.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.93 |
| Education | $59.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.90 | 2019-2023 | |
| Exeltis, USA INC. | $206.24 | 2021-2025 | Slynd |
| Aspira Women'S Health INC | $205.56 | 2021-2022 | |
| Astellas Pharma US INC | $184.42 | 2023-2025 | Veozah |
| Merz North America, INC. | $137.96 | 2020 | |
| Therapeuticsmd, INC. | $106.16 | 2020-2022 | |
| Scynexis, INC. | $90.86 | 2022 | |
| Pfizer INC. | $81.02 | 2021-2024 | |
| Agile Therapeutics, INC. | $71.74 | 2021 | |
| Amag Pharmaceuticals, INC. | $41.64 | 2019 | |
| Millicent US INC | $40.05 | 2024 | |
| Amgen INC. | $38.75 | 2020-2025 | Evenity |
| Myovant Sciences INC. | $37.46 | 2021 | |
| Allergan, INC. | $34.88 | 2019 | |
| Organon LLC | $33.37 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.23 | 2025 | Gardasil 9 |
| Exact Sciences Corporation | $29.95 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $23.59 | 2023 | Myfembree |
| Coopersurgical, INC. | $22.34 | 2022 | |
| Evofem Biosciences, INC. | $20.92 | 2024 | |
| Biogen, INC. | $20.00 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $17.64 | 2022 | |
| Shield Therapeutics INC | $15.70 | 2025 | |
| Mayne Pharma Commercial LLC | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francine Fradella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.